(Q43158404)

15 November 2017

title

KANK1, a candidate tumor suppressor gene, is fused to PDGFRB in an imatinib-responsive myeloid neoplasm with severe thrombocythemia (English)

1 reference

15 November 2017

1 reference

Jean-Baptiste Demoulin

8

1 reference

15 November 2017

S Medves

1

1 reference

15 November 2017

F P Duhoux

2

1 reference

15 November 2017

A Ferrant

3

1 reference

15 November 2017

F Toffalini

4

1 reference

15 November 2017

G Ameye

5

1 reference

15 November 2017

J-M Libouton

6

1 reference

15 November 2017

H A Poirel

7

1 reference

15 November 2017

publication date

18 February 2010

1 reference

15 November 2017

1 reference

15 November 2017

volume

24

1 reference

15 November 2017

issue

5

1 reference

15 November 2017

page(s)

1052-1055

1 reference

https://scigraph.springernature.com/pub.10.1038/leu.2010.13

15 November 2017

exact match

0 references

cites work

Classification and diagnosis of myeloproliferative neoplasms: the 2008 World Health Organization criteria and point-of-care diagnostic algorithms

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2010.13

Oncogenic derivatives of platelet-derived growth factor receptors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2010.13

Durable responses to imatinib in patients with PDGFRB fusion gene-positive and BCR-ABL-negative chronic myeloproliferative disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2010.13

Kank proteins: structure, functions and diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2010.13

Contacts between membrane proximal regions of the PDGF receptor ectodomain are required for receptor activation but not for receptor dimerization

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2010.13

Deletion of the ANKRD15 gene at 9p24.3 causes parent-of-origin-dependent inheritance of familial cerebral palsy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2010.13

Altered gene expression in myeloproliferative disorders correlates with activation of signaling by the V617F mutation of Jak2.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2010.13

A novel ETV6-PDGFRB fusion transcript missed by standard screening in a patient with an imatinib responsive chronic myeloproliferative disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2010.13

21 January 2018

Identifiers

DOI

10.1038/LEU.2010.13

1 reference

Dimensions Publication ID

15 November 2017

1005100763

0 references

1 reference